Puisieux A, Lim S, Groopman J, Ozturk M
Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center, Charlestown 02129.
Cancer Res. 1991 Nov 15;51(22):6185-9.
In lung and liver cancers, p53 mutations are mostly G:C to T:A transversions. This type of mutation is known to be induced by benzo(a)pyrene and aflatoxin B1 which are associated with the etiology of lung and liver cancers, respectively. Using a novel assay based on DNA polymerase fingerprint analysis, we identified p53 nucleotides targeted by these carcinogens. Thirteen of 14 nucleotide residues of the p53 gene which underwent G:C to T:A mutations in lung cancers were targeted by benzo(a)pyrene. Similarly, aflatoxin B1 formed adducts at a mutational hotspot specific for liver cancer. The same nucleotide (third base of codon 249), which mutates rarely in lung cancers, was not a target for benzo(a)pyrene. These in vitro observations indicate that p53 mutational hotspots identified in different tumors are selected targets specifically for the etiologically defined environmental carcinogens.
在肺癌和肝癌中,p53突变大多是从G:C到T:A的颠换。已知这种类型的突变是由苯并(a)芘和黄曲霉毒素B1分别诱导产生的,它们分别与肺癌和肝癌的病因相关。我们使用一种基于DNA聚合酶指纹分析的新型检测方法,确定了这些致癌物靶向的p53核苷酸。在肺癌中发生从G:C到T:A突变的p53基因的14个核苷酸残基中有13个被苯并(a)芘靶向。同样,黄曲霉毒素B1在肝癌特有的突变热点处形成加合物。在肺癌中很少发生突变的同一个核苷酸(密码子249的第三个碱基)不是苯并(a)芘的靶向目标。这些体外观察结果表明,在不同肿瘤中鉴定出的p53突变热点是针对病因明确的环境致癌物的特定选择靶点。